Skip to main content
Top
Published in: BMC Women's Health 1/2021

Open Access 01-12-2021 | Diabetes | Research

The association of parity/live birth number with incident type 2 diabetes among women: over 15 years of follow-up in The Tehran Lipid and Glucose Study

Authors: Seyyed Saeed Moazzeni, Reyhane Hizomi Arani, Samaneh Asgari, Fereidoun Azizi, Farzad Hadaegh

Published in: BMC Women's Health | Issue 1/2021

Login to get access

Abstract

Background

Childbearing may increase the future risk of developing type 2 diabetes mellitus (T2DM) in mothers. However, the issue is not clear completely and not investigated in the Middle East, a region with a high burden of T2DM. In the current study, we examined the association of parity/live birth number with incident T2DM among Iranian women.

Methods

The study population included 2552 women aged 30–65 years recruited in 1999–2001 and were followed for incident T2DM by 3-year intervals. Multivariable Cox proportional hazard models were applied to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of the parity/live birth number for incident T2DM. Parity number was defined as the number of live childbirth (number of live birth) plus the number of stillbirth (defined as birth of an infant that died after the 20th week of pregnancy in the uterus).

Results

During a median follow-up of 15.4 years, 557 incident T2DM cases have occurred. After adjustment for potential T2DM risk factors and reproductive factors, each additional parity caused a 9% higher risk for incident T2DM. Moreover, compared to women with one parity, those with 3 and ≥ 4 parity had HRs of 1.73 [95% CI: 1.06–2.83] and 2.23 [1.36–3.65], respectively. After further adjustment for body mass index (BMI) and waist circumference, although the HRs were attenuated prominently, parity ≥ 4 was associated with significantly higher risk (HR: 1.72 [1.05–2.83]); even after further adjustment for triglycerides (TG)/ high-density lipoprotein cholesterol (HDL-C), the risk remained marginally significant (HR: 1.64 [1.00–2.70; P value: 0.051]). For the number of live birth, the results were also similar. Moreover, in a sensitivity analysis, when we considered BMI change during follow-up as another covariate, generally, the effect sizes did not change; the trend of HRs across categories of parity number remained marginally significant (P value: 0.064).

Conclusions

During a long-term follow-up, after adjustment for potential T2DM risk factors, reproductive factors, obesity indices, and TG/HDL-C (insulin resistance surrogate), we demonstrated that higher parity/live birth numbers could be associated with increased risk of T2DM development among Iranian women. Moreover, even after further adjustment for BMI change, the suggestive higher risk was still found.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790.CrossRef Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790.CrossRef
2.
go back to reference Moazzeni SS, Ghafelehbashi H, Hasheminia M, Parizadeh D, Ghanbarian A, Azizi F, Hadaegh F. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011. BMC Public Health. 2020;20(1):1510.CrossRef Moazzeni SS, Ghafelehbashi H, Hasheminia M, Parizadeh D, Ghanbarian A, Azizi F, Hadaegh F. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011. BMC Public Health. 2020;20(1):1510.CrossRef
3.
go back to reference Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS ONE. 2014;9(7):e102563.CrossRef Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS ONE. 2014;9(7):e102563.CrossRef
4.
go back to reference Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–36.CrossRef Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–36.CrossRef
5.
go back to reference Li P, Shan Z, Zhou L, Xie M, Bao W, Zhang Y, Rong Y, Yang W, Liu L. Mechanisms in endocrinology: parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Endocrinol. 2016;175(5):R231-245.CrossRef Li P, Shan Z, Zhou L, Xie M, Bao W, Zhang Y, Rong Y, Yang W, Liu L. Mechanisms in endocrinology: parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Endocrinol. 2016;175(5):R231-245.CrossRef
6.
go back to reference Moazzeni SS, Toreyhi H, Asgari S, Azizi F, Tehrani FR, Hadaegh F. Number of parity/live birth(s) and cardiovascular disease among Iranian women and men: results of over 15 years of follow-up. BMC Pregnancy Childbirth. 2021;21(1):1–11.CrossRef Moazzeni SS, Toreyhi H, Asgari S, Azizi F, Tehrani FR, Hadaegh F. Number of parity/live birth(s) and cardiovascular disease among Iranian women and men: results of over 15 years of follow-up. BMC Pregnancy Childbirth. 2021;21(1):1–11.CrossRef
9.
go back to reference Guo P, Zhou Q, Ren L, Chen Y, Hui Y. Higher parity is associated with increased risk of type 2 diabetes mellitus in women: a linear dose–response meta-analysis of cohort studies. J Diabetes Complicat. 2017;31(1):58–66.CrossRef Guo P, Zhou Q, Ren L, Chen Y, Hui Y. Higher parity is associated with increased risk of type 2 diabetes mellitus in women: a linear dose–response meta-analysis of cohort studies. J Diabetes Complicat. 2017;31(1):58–66.CrossRef
10.
go back to reference Almahmeed B, Shah B, Mukerji G, Ling V, Booth G, Feig D. Effect of multiparity and ethnicity on the risk of development of diabetes: a large population-based cohort study. Diabet Med. 2017;34(11):1637–45.CrossRef Almahmeed B, Shah B, Mukerji G, Ling V, Booth G, Feig D. Effect of multiparity and ethnicity on the risk of development of diabetes: a large population-based cohort study. Diabet Med. 2017;34(11):1637–45.CrossRef
11.
go back to reference Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M. Metabolic health in the Middle East and north Africa. Lancet Diabetes Endocrinol. 2019;7(11):866–79.CrossRef Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M. Metabolic health in the Middle East and north Africa. Lancet Diabetes Endocrinol. 2019;7(11):866–79.CrossRef
12.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.CrossRef Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.CrossRef
13.
go back to reference World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006.
14.
go back to reference Araujo Júnior E, Peixoto AB, Zamarian AC, Elito Júnior J, Tonni G. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017;38:83–96.CrossRef Araujo Júnior E, Peixoto AB, Zamarian AC, Elito Júnior J, Tonni G. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017;38:83–96.CrossRef
15.
go back to reference American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14.CrossRef American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14.CrossRef
16.
go back to reference Pandeya N, Huxley RR, Chung HF, Dobson AJ, Kuh D, Hardy R, Cade JE, Greenwood DC, Giles GG, Bruinsma F. Female reproductive history and risk of type 2 diabetes: a prospective analysis of 126 721 women. Diabetes Obes Metab. 2018;20(9):2103–12.CrossRef Pandeya N, Huxley RR, Chung HF, Dobson AJ, Kuh D, Hardy R, Cade JE, Greenwood DC, Giles GG, Bruinsma F. Female reproductive history and risk of type 2 diabetes: a prospective analysis of 126 721 women. Diabetes Obes Metab. 2018;20(9):2103–12.CrossRef
17.
go back to reference Naver K, Lundbye-Christensen S, Gorst-Rasmussen A, Nilas L, Secher N, Rasmussen S, Ovesen P. Parity and risk of diabetes in a Danish nationwide birth cohort. Diabet Med. 2011;28(1):43–7.CrossRef Naver K, Lundbye-Christensen S, Gorst-Rasmussen A, Nilas L, Secher N, Rasmussen S, Ovesen P. Parity and risk of diabetes in a Danish nationwide birth cohort. Diabet Med. 2011;28(1):43–7.CrossRef
18.
go back to reference Gunderson EP, Lewis CE, Tsai A-L, Chiang V, Carnethon M, Quesenberry CP, Sidney S. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes. 2007;56(12):2990–6.CrossRef Gunderson EP, Lewis CE, Tsai A-L, Chiang V, Carnethon M, Quesenberry CP, Sidney S. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes. 2007;56(12):2990–6.CrossRef
19.
go back to reference Kamana K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(Suppl. 2):14–20.CrossRef Kamana K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(Suppl. 2):14–20.CrossRef
20.
go back to reference Nanri A, Mizoue T, Noda M, Goto A, Sawada N, Tsugane S. Group JPHCbPS: Menstrual and reproductive factors and type 2 diabetes risk: the Japan Public Health Center-based Prospective Study. J Diabetes Investig. 2019;10(1):147–53.CrossRef Nanri A, Mizoue T, Noda M, Goto A, Sawada N, Tsugane S. Group JPHCbPS: Menstrual and reproductive factors and type 2 diabetes risk: the Japan Public Health Center-based Prospective Study. J Diabetes Investig. 2019;10(1):147–53.CrossRef
21.
go back to reference Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2006;29(11):2349–54.CrossRef Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2006;29(11):2349–54.CrossRef
22.
go back to reference Kampmann U, Knorr S, Fuglsang J, Ovesen P. Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res. 2019;2019:5320156.CrossRef Kampmann U, Knorr S, Fuglsang J, Ovesen P. Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res. 2019;2019:5320156.CrossRef
23.
go back to reference Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum. Diabetes Care. 2014;37(12):3262–9.CrossRef Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum. Diabetes Care. 2014;37(12):3262–9.CrossRef
24.
go back to reference Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.CrossRef Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.CrossRef
25.
go back to reference Carr DB, Newton KM, Utzschneider KM, Tong J, Gerchman F, Kahn SE, Heckbert SR. Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care. 2008;31(5):1037–9.CrossRef Carr DB, Newton KM, Utzschneider KM, Tong J, Gerchman F, Kahn SE, Heckbert SR. Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care. 2008;31(5):1037–9.CrossRef
26.
go back to reference Cordero A, Alegria-Ezquerra E. TG/HDL ratio as surrogate marker for insulin resistance. E-J Cardiol Pract [Internet]. 2009;8:16. Cordero A, Alegria-Ezquerra E. TG/HDL ratio as surrogate marker for insulin resistance. E-J Cardiol Pract [Internet]. 2009;8:16.
27.
go back to reference Derakhshan A, Tohidi M, Hajebrahimi M, Saadat N, Azizi F, Hadaegh F. Sex-specific incidence rates and risk factors of insulin resistance and β-cell dysfunction: a decade follow-up in a Middle Eastern population. Diabet Med. 2017;34(2):245–52.CrossRef Derakhshan A, Tohidi M, Hajebrahimi M, Saadat N, Azizi F, Hadaegh F. Sex-specific incidence rates and risk factors of insulin resistance and β-cell dysfunction: a decade follow-up in a Middle Eastern population. Diabet Med. 2017;34(2):245–52.CrossRef
Metadata
Title
The association of parity/live birth number with incident type 2 diabetes among women: over 15 years of follow-up in The Tehran Lipid and Glucose Study
Authors
Seyyed Saeed Moazzeni
Reyhane Hizomi Arani
Samaneh Asgari
Fereidoun Azizi
Farzad Hadaegh
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2021
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01519-7

Other articles of this Issue 1/2021

BMC Women's Health 1/2021 Go to the issue